Перианальные свищи при болезни Крона (обзор литературы)

Лечение прямокишечных свищей как перианальных проявлений болезни Крона (ППБК) является важной задачей, решение которой до сих пор не найдено. В первую очередь, это связано с изнурительными, сни- жающими качество жизни, симптомами. Неправильная тактика в лечении данного заболевания может приводить к развитию анального недержания, а в ряде случаев и к удалению прямой кишки. Целью данного обзора было изучение эффективности различных хирургических методов лечения перианальных пораже- ний, особенностей их применения при различных видах свищей, а также оценка влияния оперативного лечения на функцию запирательного аппарата прямой кишки. Установлено, что большинство описанных методов применялось у строго отобранной ограниченной группы больных и позволяло лишь временно ликвидировать клинические проявления ППБК. Неудовлетворительные результаты лечения, особенно в отдаленном послеоперационном периоде, малое число клинических наблюдений в опубликованных научных работах, посвященных лечению перианальных проявлений болезни Крона, а также низкая достоверность результатов, диктуют необходимость проведения дальнейших исследований с включением большего числа пациентов.

1. Loffler T, Welsch T, Muhl S, et al. Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn’s disease. Int J Colorectal Dis. 2009;24(5):521–526. doi: 10.1007/s00384-009-0638-x

2. Bolshinsky V, Church J. Management of Complex Anorectal and Perianal Crohn’s Disease. Clin Colon Rectal Surg. 2019;32:255–260. doi: 10.1055/s-0039-1683907

3. Feuerstein JD, Cheifetz AS. Crohn disease: Epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92:1088–1103. doi: 10.1016/j.mayocp.2017.04.010

4. Panés J, Rimola J. Perianal fistulizing Crohn’s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14:652–64. doi: 10.1038/nrgastro.2017.104

5. Park SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al. Update on the natural course of fistulizing perianal Crohn’s disease in a population-based cohort. Inflamm Bowel Dis. 2019;25:1054–60. doi: 10.1093/ibd/izy329

6. Schwartz DA, Loftus EV, Jr., Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122(4):875–80. doi: 10.1053/gast.2002.32362

7. Molendijk I, Nuij VJ, van der Meulen-de Jong AE, et al. Disappointing durable remission rates in complex Crohn’s disease fistula. Inflamm Bowel Dis. 2014;20(11):2022–2028. doi: 10.1097/MIB.0000000000000148

8. Ивашкин В.Т., Шелыгин Ю.А., Абдулганиева Д.И. Клинические рекомендации по диагностике и лечению болезни Крона у взрослых (проект). Колопроктология. 2020;19(2):8–32. doi: 10.33878/2073-7556-2020-19-2-8-38

9. Sandborn WJ, Fazio VW, Feagan BG, et al. American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125:1508–30. doi: 10.1016/j.gastro.2003.08.025

10. Santillan CS, Huang C, Eisenstein S, et al. MRI of Perianal Crohn Disease: Technique and Interpretation. Top Magn Reson Imaging. 2021;1;30(1):63–76. doi: 10.1097/RMR.0000000000000268

11. van Rijn KL, Meima-van Praag EM, Bossuyt PM, et al. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn’s Disease Patients. J Crohns Colitis. 2022;16(5):708–716. doi: 10.1093/eccojcc/jjab168

12. Gallego JC, Echarri A. Role of magnetic resonance imaging in the management of perianal Crohn’s disease. Insights Imaging. 2018;9(1):47–58. doi: 10.1007/s13244-017-0579-9

13. Halligan S, Stoker J. Imaging of fistula in ano. Radiology. 2006;239:18–33.

14. Bell SJ, Halligan S, Windsor AC, et al. Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2003;17:387–93.

15. Zawadzki A, Starck M, Bohe M, Thorlacius H. A unique 3D endoanal ultrasound feature of perianal Crohn’s fistula: the ‘Crohn ultrasound fistula sign’. Colorectal Dis. 2012;14(9):e608-11. doi: 10.1111/j.1463-1318.2012.03047.x

16. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63:1381–1392. doi: 10.1136/gutjnl-2013-306709

17. Lopez N., Ramamoorthy S., Sandborn W.J. Recent advances in the management of perianal fistulizing Crohn’s disease: lessons for the clinic. Expert Rev Gastroenterol Hepatol. 2019;13(6):563–577. doi: 10.1080/17474124.2019.1608818

18. Alabiso ME, Iasiello F, Pellino G, et al. 3D-EAUS and MRI in the Activity of Anal Fistulas in Crohn’s Disease. Gastroenterol Res Pract. 2016;2016:1895694. doi: 10.1155/2016/1895694

19. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001;121:1064–72. doi: 10.1053/gast.2001.28676

20. Kotze PG, Spinelli A, Lightner AL. Cell-based Therapy for Perianal Fistulising Crohn’s Disease. Curr Pharm Des. 2019;25:41–46. doi: 10.2174/1381612825666190308095651

21. Panés J, García-Olmo D, Van Assche G, et al. ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281–1290. doi: 10.1016/S0140-6736(16)31203-X

22. Lightner AL, Wang Z, Zubair AC, et al. A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: Progress Made and Future Directions. Dis Colon Rectum. 2018;61:629–640. doi: 10.1097/DCR.0000000000001093

23. Adegbola SO, Sahnan K, Tozer PJ, et al. Review of local injection of anti-TNF for perianal fistulising Crohn’s disease. Int J Colorectal Dis. 2017;32:1539–1544. doi: 10.1007/s00384-017-2899-0

24. Dulai PS, Buckey JC Jr, Raffals LE, et al. Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial. Am J Gastroenterol. 2018;113:1516–1523. doi: 10.1038/s41395-018-0005-z

25. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63(9):1381–92. doi: 10.1136/gutjnl-2013-306709

26. El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn’s fistulas. Colorectal Dis. 2012;14(10):1217–23. doi: 10.1111/j.1463-1318.2012.02944.x

27. Lozynskyy YS. Treatment algorithms in the case of perianal complications of Crohn’s disease. Dig Dis. 2009;27(4):565–70. doi: 10.1159/000233299

28. Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. Am J Gastroenterol. 2018;113(4):481–517. doi: 10.1038/ajg.2018.27

29. Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCOESCP Consensus on Surgery for Crohn’s Disease. J Crohns Colitis. 2018;12(1):1–16. doi: 10.1093/ecco-jcc/jjx061

30. Lee MJ, Heywood N, Adegbola S, et al. Systematic review of surgical interventions for Crohn’s anal fistula. BJS Open. 2017;1(3):55– 66. doi: 10.1002/bjs5.13

31. Graf W, Andersson M, Åkerlund JE, et al. Long-term outcome after surgery for Crohn’s anal fistula. Colorectal Dis. 2016;18:80–85. doi: 10.1111/codi.13106

32. Dursun A, Hodin R, Bordeianou L. Impact of perineal Crohn’s disease on utilization of care in the absence of modifiable predictors of treatment failure. Int J Colorectal Dis. 2014;29:1535–1539. doi: 10.1007/s00384-014-2013-9

33. van Koperen PJ, Safiruddin F, Bemelman WA, et al. Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg. 2009;96(6):675–9. doi: 10.1002/bjs.6608

34. Antakia R, Shorthouse AJ, Robinson K, et al. Combined modality treatment for complex fistulating perianal Crohn’s disease. Colorectal Dis. 2013;15(2):210–6. doi: 10.1111/j.1463-1318.2012.03124.x

35. Seyfried S, Herold A. Management of Perianal Fistulas in Crohn’s Disease. Visc Med. 2019;35:338–343. doi: 10.1159/000504103

36. Boscá MM, Alós R, Maroto N, et al. Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease. Gastroenterol Hepatol. 2020;43:155–168. doi: 10.1016/j.gastrohep.2019.09.012

37. Buchanan GN, Owen HA, Torkington J, et al. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg. 2004;91:476–480. doi: 10.1002/bjs.4466

38. Chung W, Ko D, Sun C, et al. Outcomes of anal fistula surgery in patients with inflammatory bowel disease. Am J Surg. 2010;199:609– 613. doi: 10.1016/j.amjsurg.2010.01.007

39. Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg. 2010;53:299–304

40. Sugita A, Koganei K, Harada H, et al. Surgery for Crohn’s anal fistulas. J Gastroenterol. 1995;30(8):143–146

41. Uchino M, Ikeuchi H, Bando T, et al. Long-term efficacy of infliximab maintenance therapy for perianal Crohn’s disease. World J Gastroenterol. 2011;17:1174–1179. doi: 10.3748/wjg.v17.i9.1174

42. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn’s disease. Dis Colon Rectum. 2002;45(6):771–5. doi: 10.1007/s10350-004-6296-8

43. Hukkinen M, Pakarinen MP, Piekkala M, et al. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn’s disease. J Crohns Colitis. 2014;8(8):756–62. doi: 10.1016/j.crohns.2014.01.001

44. Bouguen G, Siproudhis L, Gizard E, et al. Long-term outcome of perianal fistulizing Crohn’s disease treated with infliximab. Clin Gastroenterol Hepatol. 2013;11(8):975–81 e1-4. doi: 10.1016/j.cgh.2012.12.042

45. Tanaka S, Matsuo K, Sasaki T, et al. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn’s disease: when and how were the seton drains removed? Hepatogastroenterology. 2010;57(97):3–7.

46. Kotze PG, Albuquerque IC, da Luz Moreira A, et al. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn’s disease: a Brazilian multicenter observational study. Arq Gastroenterol. 2014;51:284–289. doi: 10.1590/S0004-28032014000400004

47. Ritchie RD, Sackier JM, Hodde JP. Incontinence rates after cutting seton treatment for anal fistula. Colorectal Dis. 2009;11(6):564– 571. doi: 10.1111/j.1463-1318.2008.01713.x

48. Williams JG, MacLeod CA, Rothenberger DA et al. Seton treatment of high anal fistulae. Br J Surg. 1991;78:1159–61. doi: 10.1002/bjs.1800781004

49. Wasmann KA, de Groof EJ, Stellingwerf ME, et al. Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial. J Crohns Colitis. 2020;14:1049–1056. doi: 10.1093/ecco-jcc/jjaa004

50. de Groof EJ, Sahami S, Lucas C, et al. Treatment of perianal fistula in Crohn’s disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal Dis. 2016;18(7):667–675. doi: 10.1111/codi.13311

51. El-Gazzaz G, Hull T, Mignanelli E, et al. Analysis of function and predictors of failure in women undergoing repair of Crohn’s related rectovaginal fistula. J Gastrointest Surg. 2010;14(5):824–9. doi: 10.1007/s11605-010-1167-1

52. Andreani SM, Dang HH, Grondona P, et al. Rectovaginal fistula in Crohn’s disease. Dis Colon Rectum. 2007;50(12):2215–22. doi: 10.1007/s10350-007-9057-7

53. Jarrar A, Church J. Advancement flap repair: a good option for complex anorectal fistulas. Dis Colon Rectum. 2011;54(12):1537–41. doi: 10.1097/DCR.0b013e31822d7ddd

54. Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn’s fistula-in-ano. Dis Colon Rectum. 2010;53(4):486– 95. doi: 10.1007/DCR.0b013e3181ce8b01

55. Roper MT, Trinidad SM, Ramamoorthy SL, et al. Endorectal Advancement Flaps for Perianal Fistulae in Crohn’s Disease: Careful Patient Selection Leads to Optimal Outcomes. J Gastrointest Surg. 2019;23:2277–2284. doi: 10.1007/s11605-019-04205-0

56. Stellingwerf ME, van Praag EM, Tozer PJ, et al. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn’s high perianal fistulas. BJS Open. 2019;3:231–241. doi: 10.1002/bjs5.50129

57. van Praag EM, Stellingwerf ME, van der Bilt JDW, et al. Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn’s Disease: A Retrospective Cohort Study. J Crohns Colitis. 2020;14:757–763. doi: 10.1093/ecco-jcc/jjz181

58. Makowiec F, Jehle EC, Becker HD, et al. Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn’s disease. Br J Surg. 1995;82(5):603–6. doi: 10.1002/bjs.1800820509

59. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362:1383–1395. doi: 10.1056/NEJMoa0904492

60. DIAMOND study group. Clinical and Pharmacokinetic Factors Associated with Adalimumab-Induced Mucosal Healing in Patients with Crohn’s Disease. Clin Gastroenterol Hepatol. 2018;16:542–549. doi: 10.1016/j.cgh.2017.10.036

61. Lichtenstein G, Yan S, Bala M, et al. Infliximab Maintenance Treatment Reduces Hospitalizations, Surgeries, and Procedures in Fistulizing Crohn’s Disease. Gastro. 2005;128:862–869. doi: 10.1053/j.gastro.2005.01.048

62. Ji CC, Takano S. Clinical Efficacy of Adalimumab versus Infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn’s disease. Intest Res. 2017;15(2):182–186. doi: 10.5217/ir.2017.15.2.182

63. Regh KL, Sanchez JE, Krieger BR, et al. Fecal diversion in perirectal fistulizing Crohn’s disease is an underutilized and potentially temporary means of successful treatment. Am Surg. 2009;75(8):715–8.

64. Kotze PG, Shen B, Lightner A, et al. Modern management of perianal fistulas in Crohn’s disease: future directions. Gut. 2018;67:1181–1194. doi: 10.1136/gutjnl-2017-314918

65. Wood T, Truong A, Mujukian A, et al. Increasing experience with the LIFT procedure in Crohn’s disease patients with complex anal fistula. Tech Coloproctol. 2022;26(3):205–212. doi: 10.1007/s10151-022-02582-4

66. Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn’s disease. Ann Surg. 2014;260(6):1057–61. doi: 10.1097/SLA.0000000000000479

67. Kaminski JP, Zaghiyan K, Fleshner P. Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn’s disease: what have we learned? Colorectal Dis. 2017;19(8):750–755. doi: 10.1111/codi.13668

68. Grolich T, Skricka T, Robek O, et al. Role of video assisted anal fistula treatment in our management of fistula-in-ano. Acta Chir Iugosl. 2014;61(2):83–5. doi: 10.2298/ACI1402083G

69. Emile SH, Elfeki H, Shalaby M, et al. A Systematic review and meta-analysis of the efficacy and safety of video-assisted anal fistula treatment (VAAFT). Surg Endosc. 2018;32(4):2084–2093. doi: 10.1007/s00464-017-5905-2

70. Schwandner O. Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn’s disease. Tech Coloproctol. 2013;17(2):221–225. doi: 10.1007/s10151-012-0921-7

71. Adegbola SO, Sahnan K, Tozer PJ, et al. Symptom Amelioration in Crohn’s Perianal Fistulas Using Video-Assisted Anal Fistula Treatment (VAAFT). J Crohns Colitis. 2018;12:1067–1072. doi: 10.1093/eccojcc/jjy071

72. Wilhelm A., Fiebig A., Krawezak M. Five years of experience with the FiLaC laser for fistula-in-ano management long-term follow up from a single institution. Tech Coloproctol. 2017;21:269–276. doi: 10.1007/s10151-017-1599-7

73. Матинян А.В., Костарев И.В., Благодарный Л.А., и соавт. Лечение свищей прямой кишки методом лазерной термооблитерации свищевого хода (систематический обзор). Колопроктология. 2019;18(3):7–19. doi: 10.33878/2073-7556-2019-18-3-7-19

74. Mustafa CT, Cihan A, et al. Closing Perianal Fistulas Using a Laser: Long-Term Results in 103 Patients. Dis Colon Rectum. 2018;61:5:00– 00. doi: 10.1097/DCR.0000000000001038

75. Elfeki H, Shalaby M, Emile SH, et al. A systematic review and meta-analysis of the safety and efficacy of fistula laser closure. Tech Coloproctol. 2020;24(4):265–274. doi: 10.1007/s10151-020-02165-1

76. Moy J, Bodzin J. Carbon dioxide laser ablation of perianal fistulas in patients with Crohn’s disease: experience with 27 patients. Am J Surg. 2006;191:424–427. doi: 10.1016/j.amjsurg.2005.10.050

77. Stijns J, van Loon YT, Clermonts SHEM, et al. Implementation of laser ablation of fistula tract (LAFT) for perianal fistulas: do the results warrant continued application of this technique? Tech Coloproctol. 2019;23:1127–1132. doi: 10.1007/s10151-019-02112-9

78. Alam A, Lin F, Fathallah N, et al. FiLaC® and Crohn’s disease perianal fistulas: a pilot study of 20 consecutive patients. Tech Coloproctol. 2020;24:75–78. doi: 10.1007/s10151-019-02134-3

79. Cao D, Li W, Ji Y, et al. Efficacy and safety of FiLaC™ for perianal fistulizing Crohn’s disease: a systematic review and meta-analysis. Tech Coloproctol. 2022;26(10):775–781. doi: 10.1007/s10151-022-02682-1

80. O’Riordan JM, Datta I, Johnston C, et al. A systematic review of the anal fistula plug for patients with Crohn’s and non-Crohn’s related fistula-in-ano. Dis Colon Rectum. 2012;55(3):351–358. doi: 10.1097/DCR.0b013e318239d1e4

81. Nasseri Y, Cassella L, Berns M, et al. The anal fistula plug in Crohn’s disease patients with fistula-in-ano: a systematic review. Colorectal Dis. 2016;18(4):351–356. doi: 10.1111/codi.13268

82. Senéjoux A, Siproudhis L, Abramowitz L, et al. Thérapeutique des Affections Inflammatoires du tube Digestif [GETAID] Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial. J Crohns Colitis. 2016;10:141–148. doi: 10.1093/ecco-jcc/jjv162

83. Grimaud JC, Munoz-Bongrand N, Siproudhis L, et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2010;138(7):2275–2281,2281 e2271. doi: 10.1053/j.gastro.2010.02.013

84. Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn’s Disease. Surg Clin North Am. 2019;99:1151–1162. doi: 10.1016/j.suc.2019.08.012

85. Yamamoto T, Bain IM, Allan RN, et al. Persistent perineal sinus after proctocolectomy for Crohn’s disease. Dis Colon Rectum. 1999;42:96–101. doi: 10.1007/BF02235190

86. Singh S, Ding NS, Mathis KL, et al. Systematic review with metaanalysis: faecal diversion for management of perianal Crohn’s disease. Aliment Pharmacol Ther. 2015;42(7):783–792. doi: 10.1111/apt.13356

87. Coscia M, Gentilini L, Laureti S, et al. Risk of permanent stoma in extensive Crohn’s colitis: the impact of biological drugs. Colorectal Dis. 2013;15(9):1115–22. doi: 10.1111/codi.12249

88. Mueller MH, Geis M, Glatzle J, Kasparek M, et al. Risk of fecal diversion in complicated perianal Crohn’s disease. J Gastrointest Surg. 2007;11(4):529–37. doi: 10.1007/s11605-006-0029-3

89. de Groof EJ, van der Meer JHM, Tanis PJ, et al. Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn’s Disease. J Crohns Colitis. 2019;13:285– 293. doi: 10.1093/ecco-jcc/jjy131

90. Zabot GP, Cassol O, Saad-Hossne R, et al. Modern surgical strategies for perianal Crohn’s disease. World J Gastroenterol. 2020;26(42):6572–6581. doi: 10.3748/wjg.v26.i42.6572

91. Шелыгин Ю.А., Кашников В.Н., Болихов К.В. и соавт. Предикторы эффективности илеостомии при осложненных формах болезни Крона толстой кишки. Анналы хирургии. 2012;3:37–42.